We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Innovative Technique Diagnoses Intestinal Parasitic Infections

By LabMedica International staff writers
Posted on 12 Aug 2013
Print article
Image: The fill-FLOTAC and mini-FLOTAC Devices (Photo courtesy of San Raffaele Hospital).
Image: The fill-FLOTAC and mini-FLOTAC Devices (Photo courtesy of San Raffaele Hospital).
A recently developed method for directly diagnosing intestinal parasites has been evaluated in the field and compared with standard methodology.

Soil-transmitted helminthes and intestinal protozoa infection are widespread in developing countries, yet an accurate diagnosis is rarely performed as the highly trained laboratory scientists required are seldom available in poor resource settings.

Microbiologists at the San Raffaele Hospital (Milan, Italy) in collaboration with others, analyzed stool samples from 180 pupils from two primary schools in India and Tanzania. Three diagnostic methods were used: direct fecal smear, formol-ether concentration method (FECM) and mini-FLOTAC. The latter is a simplified device and one of the main advantages of this method is that it can be more easily transferred and carried out in laboratories with limited facilities as there is no centrifugation required. The mini-FLOTAC comprises two physical components, the base and the reading disc. There are two 1-mL flotation chambers, which are designed for optimal examination of fecal sample suspensions in each flotation chamber and which permits a maximum magnification of ×400.

Overall, 72% of the pupils were positive for any intestinal parasitic infection, 24% carried dual infections, and 11% had three infections or more. The most frequently encountered intestinal parasites were Entamoeba coli, Entamoeba histolytica/dispar, Giardia intestinalis, hookworm, and Schistosoma mansoni in Tanzania. Significant differences were found in the detection of parasitic infections among the three methods. The mini-FLOTAC was the most sensitive method for helminthic infections at 90%, for the FECM provided 60% detection, and only 30% for the direct fecal smear. However, the FECM was the most sensitive for intestinal protozoa infections at 88% with 70% for direct fecal smear, and 68% for the mini-FLOTAC.

The authors concluded that the mini-FLOTAC for the diagnosis of intestinal helminthes and protozoa is a valid, sensitive, and potentially low-cost alternative technique that could be used in resource-limited settings, particularly for helminthic diagnosis. The mini-FLOTAC and fill-FLOTAC were invented and patented by Prof. Giuseppe Cringoli (University of Naples Federico II, Italy).

Related Links:

San Raffaele Hospital
University of Naples Federico II


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.